Cite

HARVARD Citation

    Wijburg, M. et al. (2016). MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. Journal of neurology, neurosurgery and psychiatry. 87 (10), pp. 1138-1145. [Online]. 
  
Back to record